CCRA Site Initiation, Qualification, and Close-Out Procedures 1 — Questions and Answers
Question 1: What is the PRIMARY purpose of a Site Qualification Visit (SQV) conducted by a CRA?
- To train site staff on the study protocol procedures
- To assess the site's capability and resources to conduct the clinical trial (Correct answer)
- To collect completed Case Report Forms from previous studies
- To deliver investigational product to the site pharmacy
Correct answer: To assess the site's capability and resources to conduct the clinical trial
The SQV evaluates whether the site has adequate facilities, staff expertise, patient population, and regulatory infrastructure to successfully conduct the trial.
Question 2: During a Site Initiation Visit (SIV), which of the following is the CRA's MOST critical responsibility?
- Reviewing all previously published literature on the investigational product
- Ensuring all site staff are trained and documented on the protocol before enrollment begins (Correct answer)
- Requesting a list of all patients who may be eligible for the study
- Submitting the final Clinical Study Report to the IRB
Correct answer: Ensuring all site staff are trained and documented on the protocol before enrollment begins
The SIV ensures all site personnel are adequately trained and that training documentation is complete before the first subject is enrolled.
Question 3: Which document must be reviewed and filed in the Trial Master File (TMF) BEFORE initiating a clinical trial site?
- Final signed Clinical Study Report
- IRB/IEC approval letter and approved informed consent form (Correct answer)
- Completed database lock confirmation
- Post-market surveillance report
Correct answer: IRB/IEC approval letter and approved informed consent form
IRB/IEC approval of the protocol and informed consent form is a regulatory prerequisite that must be on file before any study activities commence at the site.
Question 4: What is the primary goal of a Site Close-Out Visit (COV)?
- To randomize the final cohort of study subjects
- To resolve all outstanding issues, account for investigational product, and ensure proper archiving of records (Correct answer)
- To submit the IND application to the FDA
- To conduct final statistical analysis of collected data
Correct answer: To resolve all outstanding issues, account for investigational product, and ensure proper archiving of records
The COV ensures all data queries are resolved, unused investigational product is reconciled and returned or destroyed, and all trial documents are archived per regulatory requirements.
Question 5: Which of the following is a key item verified during a site qualification visit regarding investigator qualifications?
- The investigator's publication count in peer-reviewed journals
- The investigator's current medical license, CV, and relevant training and experience (Correct answer)
- The investigator's personal financial statements
- The number of vacation days the investigator takes annually
Correct answer: The investigator's current medical license, CV, and relevant training and experience
ICH E6 requires that investigators be qualified by education, training, and experience to assume responsibility for trial conduct, which is verified via CV and licensure.
Question 6: At a Site Initiation Visit, the CRA discovers the site's designated pharmacy lacks proper temperature-controlled storage for the investigational product. What should the CRA do?
- Allow enrollment to begin but document the finding in the monitoring report
- Immediately halt the site initiation and require corrective action before enrollment begins (Correct answer)
- Instruct the site to store the product at room temperature temporarily
- Report the finding to the FDA directly without informing the sponsor
Correct answer: Immediately halt the site initiation and require corrective action before enrollment begins
Inadequate storage conditions violate GCP and could compromise product integrity and subject safety; enrollment must not begin until compliant storage is confirmed.
Question 7: Which of the following best describes the Trial Master File (TMF) in the context of site initiation?
- A file containing only the financial agreements between sponsor and site
- A comprehensive collection of essential documents that individually and collectively permit evaluation of the conduct of a trial (Correct answer)
- A database used exclusively by the FDA to evaluate clinical trials
- A summary document generated only after study completion
Correct answer: A comprehensive collection of essential documents that individually and collectively permit evaluation of the conduct of a trial
Per ICH E6, the TMF contains essential documents that allow reconstruction of trial conduct and is maintained by both the sponsor and investigator throughout the trial.
CCRA Site Initiation, Qualification, and Close-Out Procedures 1
What is the PRIMARY purpose of a Site Qualification Visit (SQV) conducted by a CRA?